vimarsana.com
Home
Live Updates
RETHINC Takes Air Out of COPD-like Therapy for Smokers : vimarsana.com
RETHINC Takes Air Out of COPD-like Therapy for Smokers
Dual-acting bronchodilators were no better than placebo for symptoms in smokers without airway obstruction.
Related Keywords
Ann Arbor ,
Michigan ,
United States ,
Canada ,
United Kingdom ,
Manchester ,
Vancouver ,
British Columbia ,
British ,
Meilank Han ,
Dave Singh ,
Global Initiative For Chronic Obstructive Lung Disease ,
National Center ,
Sunovion Pharmaceuticals ,
Pulmonary Trials ,
University Of Manchester ,
European Respiratory Society Congress ,
Translational Sciences ,
University Of Michigan ,
University Of British Columbia ,
European Respiratory Society ,
Novartis Pharmaceuticals ,
Blood Institute ,
National Heart ,
Redefining Therapy In Early ,
Pulmonary Trials Cooperative ,
New England Journal ,
Global Initiative ,
Chronic Obstructive Lung Disease ,
Respiratory Questionnaire ,
Advancing Translational Sciences ,
Respiratory Society Congress ,
Chronic Obstructive Pulmonary Disease Copd ,
Chronic Obstructive Pulmonary Disease ,
Copd ,
Chronic Bronchitis ,
Bronchodilator ,
Dyspnea ,
Cough ,
Otolaryngology ,
Nt Ears ,
Nose ,
Throat ,
Pulmonary Function Testing ,
Spirometry ,
Smoking ,
Smoker ,
Tobacco Cessation ,
Uitting Tobacco Use ,
Asthma ,
Sthmatic ,
Inhaled Corticosteroids ,
Intranasal Corticosteroids ,
Nasal Corticosteroids ,
vimarsana.com © 2020. All Rights Reserved.